Literature DB >> 16103700

Comparison of antimicrobial resistance of Acinetobacter baumannii clinical isolates from Shanghai and Hong Kong.

Thomas K W Ling1, Chun Mei Ying, Ching Ching Lee, Zhi Kai Liu.   

Abstract

OBJECTIVE: To compare the antimicrobial resistance patterns of Acinetobacter baumannii isolates from Shanghai and Hong Kong.
MATERIALS AND METHODS: A total of 212 A. baumannii strains of one isolate per patient were collected from Shanghai and Hong Kong from August 2002 to August 2003 that were tested against 15 commonly used antimicrobial agents by the agar dilution method according to the NCCLS guidelines.
RESULTS: Most beta-lactams showed no significant increase in activity after adding beta-lactamase inhibitors. The resistance rates of the isolates against ticarcillin-clavulanate, piperacillin-tazobactam and ampicillin-sulbactam were for Shanghai 74.9, 70.9, 69.1% and Hong Kong 24.3, 18.9, 13.5%, respectively. Only cefoperazone-sulbactam showed a significant increase in activity against both Shanghai and Hong Kong strains, as the resistance rates dropped from 93.7 to 8.6% and 83.8 to 5.4%, respectively. The resistance rates of ceftazidime, cefepime, and gentamicin against Shanghai strains were 69.7, 72.0, 73.7% and Hong Kong strains 69.7, 29.7, 18.9%, respectively. About 65% of Shanghai strains were found to be amikacin-resistant, however, all Hong Kong strains were sensitive. Fluoroquinolones including ciprofloxacin and levofloxacin had resistance rates over 60% against Shanghai strains, but only 13.5% against Hong Kong strains. Shanghai strains had imipenem and meropenem resistance rate of 6.3%. Though 10.8% Hong Kong strains were resistant to meropenem, only 2.7% of them were resistant to imipenem.
CONCLUSION: A. baumannii isolated from Shanghai were more resistant to all drugs except meropenem than Hong Kong isolates. The results indicate a need for measures to control the abuse of antibiotic usage in order to prevent the emergence of more multidrug-resistant isolates in both cities.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16103700     DOI: 10.1159/000086932

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  6 in total

1.  Molecular Analyses of Biofilm-Producing Clinical Acinetobacter baumannii Isolates from a South Indian Tertiary Care Hospital.

Authors:  Balaram Khamari; Manmath Lama; Chanakya Pachi Pulusu; Amarendra Pratap Biswal; Sai Manoz Lingamallu; Bhargava Sai Mukkirla; Amit Kumar Sahoo; Harioum Sambhu Narayan Dash; Rewa Sharda; Prakash Kumar; Eswarappa Pradeep Bulagonda
Journal:  Med Princ Pract       Date:  2020-05-07       Impact factor: 1.927

2.  Antimicrobial stewardship program directed at broad-spectrum intravenous antibiotics prescription in a tertiary hospital.

Authors:  V C C Cheng; K K W To; I W S Li; B S F Tang; J F W Chan; S Kwan; R Mak; J Tai; P Ching; P L Ho; W H Seto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-09-01       Impact factor: 3.267

3.  First multicenter study on multidrug resistant bacteria carriage in Chinese ICUs.

Authors:  Xiaojun Ma; Yinghong Wu; Liuyi Li; Qian Xu; Bijie Hu; Yuxing Ni; Anhua Wu; Shumei Sun; Vincent Jarlier; Jérôme Robert
Journal:  BMC Infect Dis       Date:  2015-08-21       Impact factor: 3.090

4.  Evaluation of Ciprofloxacin (gyrA, parC Genes) and Tetracycline (tetB Gene) Resistance in Nosocomial Acinetobacter baumannii Infections.

Authors:  Jamileh Nowroozi; Abbas Akhavan Sepahi; Lida Tahmasebinejad Kamarposhti; Roya Razavipour; Flor Mazhar
Journal:  Jundishapur J Microbiol       Date:  2014-02-01       Impact factor: 0.747

5.  Emerging threat of multidrug resistant bugs--Acinetobacter calcoaceticus baumannii complex and methicillin resistant Staphylococcus aureus.

Authors:  Shyam Kumar Mishra; Basista Prasad Rijal; Bharat Mani Pokhrel
Journal:  BMC Res Notes       Date:  2013-03-15

6.  Clinico-epidemiological profile of Acinetobacter and Pseudomonas infections, and their antibiotic-resistant pattern in a tertiary care center, Western Nepal.

Authors:  Shankar Baral; Anjila Pokharel; Supram Hosuru Subramanya; Niranjan Nayak
Journal:  Nepal J Epidemiol       Date:  2019-12-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.